ICON PLC Total Liab Over Time
| ICLR Stock | USD 319.28 2.74 0.85% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ICON PLC Performance and ICON PLC Correlation. ICON |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICON PLC. If investors know ICON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICON PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.596 | Earnings Share 8.24 | Revenue Per Share 100.023 | Quarterly Revenue Growth 0.057 | Return On Assets 0.0401 |
The market value of ICON PLC is measured differently than its book value, which is the value of ICON that is recorded on the company's balance sheet. Investors also form their own opinion of ICON PLC's value that differs from its market value or its book value, called intrinsic value, which is ICON PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICON PLC's market value can be influenced by many factors that don't directly affect ICON PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICON PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICON PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICON PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Liab Analysis
Compare ICON PLC and related stocks such as Fonar, Burning Rock Biotech, and Sera Prognostics Total Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FONR | 18.1 M | 22.5 M | 35.4 M | 30.9 M | 25.7 M | 24.1 M | 15.9 M | 16.1 M | 15.4 M | 54 M | 54.1 M | 53.1 M | 49.8 M | 57.2 M | 33.7 M |
| BNR | 976.1 M | 976.1 M | 976.1 M | 976.1 M | 976.1 M | 976.1 M | 976.1 M | 976.1 M | 976.1 M | 1.7 B | 242 M | 433.3 M | 429.1 M | 271.6 M | 258 M |
| SERA | 129.9 M | 129.9 M | 129.9 M | 129.9 M | 129.9 M | 129.9 M | 129.9 M | 129.9 M | 129.9 M | 129.9 M | 140.4 M | 8.5 M | 17.4 M | 25.3 M | 24 M |
| PMD | 200 K | 2.8 M | 2.9 M | 4.3 M | 11.2 M | 10.7 M | 9.4 M | 7.9 M | 6.2 M | 10.7 M | 11.5 M | 9.3 M | 8 M | 6.6 M | 4.2 M |
| DRIO | 3.4 M | 3.4 M | 3.4 M | 4.2 M | 5.6 M | 4.3 M | 10.4 M | 3 M | 5.2 M | 5.7 M | 7.3 M | 15.2 M | 39.2 M | 38.2 M | 40.2 M |
| STIM | 201.9 M | 201.9 M | 201.9 M | 201.9 M | 201.9 M | 201.9 M | 201.9 M | 231.6 M | 46 M | 52.3 M | 53.2 M | 56 M | 59.8 M | 81.6 M | 78.2 M |
| CSTL | 24.1 M | 24.1 M | 24.1 M | 24.1 M | 24.1 M | 24.1 M | 24.1 M | 24.1 M | 32.5 M | 34.6 M | 23.6 M | 50.8 M | 48.2 M | 86.5 M | 47.2 M |
| XGN | 6.4 M | 6.4 M | 6.4 M | 16 M | 31.2 M | 36.8 M | 25 M | 25 M | 35.6 M | 32.7 M | 36.5 M | 38.5 M | 43.8 M | 34.2 M | 33.7 M |
| NEOG | 9.3 M | 32.5 M | 31 M | 39 M | 41.2 M | 47.6 M | 56.7 M | 57.8 M | 57.8 M | 72 M | 79.8 M | 105.6 M | 1.4 B | 1.6 B | 1.7 B |
ICON PLC and related stocks such as Fonar, Burning Rock Biotech, and Sera Prognostics Total Liab description
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.My Equities
My Current Equities and Potential Positions
| ICON PLC | ICLR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Ireland |
| Exchange | NASDAQ Exchange |
USD 319.28
Additional Tools for ICON Stock Analysis
When running ICON PLC's price analysis, check to measure ICON PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICON PLC is operating at the current time. Most of ICON PLC's value examination focuses on studying past and present price action to predict the probability of ICON PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICON PLC's price. Additionally, you may evaluate how the addition of ICON PLC to your portfolios can decrease your overall portfolio volatility.